EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -3.658
March 31, 2026 -73.83
December 31, 2025 -83.69
September 30, 2025 -55.46
June 30, 2025 -36.64
March 31, 2025 -62.99
December 31, 2024 -151.70
September 30, 2024 58.82
June 30, 2024 -130.74
March 31, 2024 -528.50
December 31, 2023 -226.90
September 30, 2023 -247.93
June 30, 2023 -236.28
March 31, 2023 -376.22
December 31, 2022 -373.06
September 30, 2022 -430.73
Date Value
June 30, 2022 -477.45
March 31, 2022 -521.64
December 31, 2021 -697.40
September 30, 2021 -703.86
June 30, 2021 -573.12
March 31, 2021 -666.69
December 31, 2020 -749.70
September 30, 2020 -725.12
June 30, 2020 -513.36
March 31, 2020 -489.65
December 31, 2019 -772.86
September 30, 2019 -3976.17
June 30, 2019 -600.00
March 31, 2019 -3056.04
December 31, 2018 -356.61
September 30, 2018 -3037.09

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
Anika Therapeutics, Inc. 0.2412
BioCryst Pharmaceuticals, Inc. 0.2957
Imunon, Inc. -0.5412